Name: UMIN ID:
Unique ID issued by UMIN | UMIN000029622 |
---|---|
Receipt number | R000033110 |
Scientific Title | Analysis of intratumoral immune response early on Nivolumab treatment in unresectable advanced or recurrent gastric cancer. |
Date of disclosure of the study information | 2017/10/19 |
Last modified on | 2023/04/24 15:04:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/10/19 09:54:35 | ||
2 | Update | 2017/10/25 08:01:52 | Organization Organization |
|
3 | Update | 2017/11/27 17:34:18 | Recruitment status |
|
4 | Update | 2017/11/27 17:34:50 | Anticipated trial start date |
|
5 | Update | 2017/12/04 17:30:24 | Key inclusion criteria Key inclusion criteria |
|
6 | Update | 2017/12/04 17:42:54 | Key inclusion criteria |
|
7 | Update | 2017/12/05 14:28:27 | Key inclusion criteria Key exclusion criteria |
|
8 | Update | 2020/04/23 13:46:53 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
9 | Update | 2022/11/13 16:43:17 | Recruitment status Date of IRB Last follow-up date |
|
10 | Update | 2023/04/24 15:04:14 | Number of participants that the trial has enrolled |